Subject: The "Saturation" Flaw: Why Weekly GLP-1/Glucagon Blasts are Ruining Your Vasculature (And how to fix it with a 3-on/5-off Surge)
The Problem: The Weekly Sag
Most of you are running Retatrutide or Tirzepatide on the standard weekly schedule. Here’s the engineering failure: A 12mg weekly shot sags by ~56% before your next pin. This creates a "Weekly Wave."
Even if your blood sugar "average" (A1C) is low, the Coefficient of Variation (CV) is high. That oscillation isn't just a number—it’s physical vascular vibration. It creates shear stress on your endothelial lining (heart/kidneys) every single week. Plus, constant saturation leads to receptor "deafness."
The Prussian Solution: The 3-on/5-off "Active Dampening" Surge
Instead of the weekly blast, I’m running a 333 mcg daily surge for 3 days, followed by a 5-day reset.
Why this out-engineers the standard "Bro-dose":
The Signal Floor: By redosing daily for 3 days, you build a "reservoir" that stays above the 50% floor. This provides Active Dampening—it keeps the "Glucagon Governor" engaged so your liver never initiates those late-week glucose dumps. The 49.47% Reset: The 5-day "off" window is the mathematical "Sweet Spot." It allows for a ~50% drop in signal—enough to let your receptors "breathe" and stay sensitive (preventing burnout), but not enough to let the glucose floor collapse. Vascular Stability: This narrows the glucose swing by ~50% compared to clinical trials. You aren't just "in range"; you've eliminated the vibration that tears up your micro-vessels.
The Data (333 mcg Daily x 3 Days):
Peak (C_{max}): ~1,481 mcg (High Saturation) Trough (C_{min}): ~748 mcg (The Breath) Glucose CV: Targeted 7–10% (Non-Diabetic Stability)
The Engineering Verdict:
Clinical trials solve for "Average." We solve for Structural Integrity. If you’re pushing high-performance cycles, you need a stable metabolic floor, not a weekly roller coaster. Stop treating your metabolism like a light switch and start treating it like a tuned engine.
Supporting documents 3. Endothelial Stability & Glucose Variability (CV% Metrics)
• The 36% Threshold: Maintain CV < 36% to avoid "Shear Stress" on endothelial cells.
• The Risk: CV ≥ 36% causes basement membrane thickening (Retinopathy/Nephropathy).
• MAGE Metric: Swings > 60 mg/dL trigger acute inflammatory pathways.
4. Clinical Trial References
• TRANSCEND-T2D-1: Stepwise titration model (2mg → 12mg).
• TRANSCEND-T2D-3 (NCT06297603): Focus on patients on basal insulin.
• TRIUMPH-3 (NCT05882045): Obesity and CV focus.
Goal: Maintain a stable glycemic band to protect micro-vascular integrity.
I've sent this over to Tony huge ill see if he replies with a review. If anyone was wondering i revised this off a logic I learned from guru ameen. BTW visit www.freeameen.org more updates comeing to the site this week.
The Problem: The Weekly Sag
Most of you are running Retatrutide or Tirzepatide on the standard weekly schedule. Here’s the engineering failure: A 12mg weekly shot sags by ~56% before your next pin. This creates a "Weekly Wave."
Even if your blood sugar "average" (A1C) is low, the Coefficient of Variation (CV) is high. That oscillation isn't just a number—it’s physical vascular vibration. It creates shear stress on your endothelial lining (heart/kidneys) every single week. Plus, constant saturation leads to receptor "deafness."
The Prussian Solution: The 3-on/5-off "Active Dampening" Surge
Instead of the weekly blast, I’m running a 333 mcg daily surge for 3 days, followed by a 5-day reset.
Why this out-engineers the standard "Bro-dose":
The Signal Floor: By redosing daily for 3 days, you build a "reservoir" that stays above the 50% floor. This provides Active Dampening—it keeps the "Glucagon Governor" engaged so your liver never initiates those late-week glucose dumps. The 49.47% Reset: The 5-day "off" window is the mathematical "Sweet Spot." It allows for a ~50% drop in signal—enough to let your receptors "breathe" and stay sensitive (preventing burnout), but not enough to let the glucose floor collapse. Vascular Stability: This narrows the glucose swing by ~50% compared to clinical trials. You aren't just "in range"; you've eliminated the vibration that tears up your micro-vessels.
The Data (333 mcg Daily x 3 Days):
Peak (C_{max}): ~1,481 mcg (High Saturation) Trough (C_{min}): ~748 mcg (The Breath) Glucose CV: Targeted 7–10% (Non-Diabetic Stability)
The Engineering Verdict:
Clinical trials solve for "Average." We solve for Structural Integrity. If you’re pushing high-performance cycles, you need a stable metabolic floor, not a weekly roller coaster. Stop treating your metabolism like a light switch and start treating it like a tuned engine.
Supporting documents 3. Endothelial Stability & Glucose Variability (CV% Metrics)
• The 36% Threshold: Maintain CV < 36% to avoid "Shear Stress" on endothelial cells.
• The Risk: CV ≥ 36% causes basement membrane thickening (Retinopathy/Nephropathy).
• MAGE Metric: Swings > 60 mg/dL trigger acute inflammatory pathways.
4. Clinical Trial References
• TRANSCEND-T2D-1: Stepwise titration model (2mg → 12mg).
• TRANSCEND-T2D-3 (NCT06297603): Focus on patients on basal insulin.
• TRIUMPH-3 (NCT05882045): Obesity and CV focus.
Goal: Maintain a stable glycemic band to protect micro-vascular integrity.
I've sent this over to Tony huge ill see if he replies with a review. If anyone was wondering i revised this off a logic I learned from guru ameen. BTW visit www.freeameen.org more updates comeing to the site this week.
